Karin Conde-Knape

Research Topics

by # Publications/# Citations
  • Signs and Symptoms
  • Diseases

Register to see all

Co-author network

Co-author # Co-publications
Co-author # Co-publications

Register to see all


Top 5
# Referenced

Potent, selective MCH-1 receptor antagonists.

2008: B Banner; S Berthel; K Conde-Knape; SD Erickson; F Falcioni; I Hakimi; B Hennessy; RF Kester; K Kim; C Ma; W McComas; F Mennona; S Mischke; L Orzechowski; Y Qian; H Salari; R Taub; J Tengi; K Thakkar; JW Tilley; H Wang;

Potent MCH-1 receptor antagonists from cis-1,4-diaminocyclohexane-derived indane analogs.

2013: K Conde-Knape; SD Erickson; F Falcioni; P Gillespie; I Hakimi; F Mennona; Y Qian; Y Ren; H Salari; SS So; JW Tilley;

Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists.

2013: G Bose; K Conde-Knape; P Gillespie; RA Goodnow; K Moulik; M Myers; S Pietranico-Cole; G Saha; SS So; C Zwingelstein;

Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

2014: JA Bilotta; K Conde-Knape; N Fotouhi; P Gillespie; RA Goodnow; KR Guertin; MM Hamilton; NE Haynes; B Liu; M Myers; S Pietranico-Cole; L Qi; Y Ren; NR Scott; SS So; C Spence; R Taub; K Thakkar; JW Tilley; C Zwingelstein;

Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.

2014: B Banner; K Conde-Knape; S Danzi; M Dvorozniak; NE Haynes; KS Huang; MJ Kelly; I Klein; JD Larigan; F Mennona; S Pietranico-Cole; Y Qian; CH Reynolds; N Scott; SS So; R Taub; K Thakkar; J Tilley; J Vermeulen;

Register to see all


Columbia University

Register to see all

No map available!

Title and Abstract from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Data mined from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Last MEDLINE®/PubMed® update: 1st of December 2015